Medical Marijuana, Inc. (OTCMKTS:MJNA) Logs New 52-Week Low

To say that 2015 has not been favorable to Medical Marijuana, Inc. (OTCMKTS:MJNA) would be an understatement. The company’s stock is about 45% down year to date. In yesterday’s session MJNA carved yet another 52-week low, closing 5% down at $0.0745 per share.

MJNA has kept a low PR profile over the last few weeks. The company put up a flurry of releases on April 20 to celebrate the 420 holiday. However, this year none of the pot stocks managed to get a free boost just because of a number on the calendar.

MJNA’s due annual report is still missing, but that was more or less expected, considering the company’s track history with timely filings. There was a notification of late filing on March 30 – the regular deadline for the report. The extension granted by the notification expired more than three weeks ago, on April 13. The report is still missing, which explains why MJNA is currently stamped with the “STOP” sign on OTC Markets and is labeled as “Pink No Information”.

The company’s future reports would make for a more interesting read as those should contain figures coming from KannaWay – MJNA’s latest acquisition, which is now practically the constant highlight of press releases.

In previous articles we examined the rather tangled relationships that exist between KannaWay, MJNA’s new CEO Stuart Titus and his General Hemp business. It seems having such an experienced pot sector businessman at the helm of MJNA is not doing the company any favors so far.